ABBV-950
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV-950, covering 2024-07-01 to 2024-07-01. Get the full timeline:
Most recent: Clinical Trial Update: Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Spasticity [Phase 1]